New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

[
New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer
[og_img]
https://www.investing.com/news/press-releases/new-data-demonstrated-bestinclass-potential-for-casdatifan-a-hif2a-inhibitor-in-patients-with-metastatic-kidney-cancer-93CH-3871845


Investing.com